Engaged Capital Reaches Agreement with Aratana Therapeutics for Board Representation

Reuters, StreetInsider and other media sources reported on the agreement reached between Olshan client Engaged Capital and Aratana Therapeutics. Pursuant to the agreement, two independent directors, Craig Barbarosh and Lowell Robinson, were appointed to Aratana’s Board of Directors, effective immediately. Steve Wolosky and Ryan Nebel represent Engaged Capital in connection with its investment in Aratana Therapeutics.